A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis
Seunghoon Han,1,2 Gun Hyung Na,3 Dong-Goo Kim3 1Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, South Korea; 2Pharmacometrics Institute for Practical Education and Training, The Catholic University of Korea, Seocho-gu, Seoul, South Korea; 3Departm...
Saved in:
Main Authors: | Han S (Author), Na GH (Author), Kim DG (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
by: Megan K. Young
Published: (2019) -
Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome
by: J Gordon Millichap
Published: (2010) -
Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
by: Delphine Laho, et al.
Published: (2021) -
Intravenous immunoglobulin in dermatology
by: Dhar Sandipan
Published: (2009) -
INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
by: A.Yu. Shcherbina, et al.
Published: (2010)